Literature DB >> 88983

A critical evaluation of the results of transurethral resection of the prostate.

C P Chilton, R J Morgan, H R England, A M Paris, J P Blandy.   

Abstract

In a review of 1057 consecutive prostatectomies of which 95% were performed transurethrally, carcinoma was present in 11.8%. There were 10 deaths within a month of operation (0.9%), 9 of these patients having been exceptionally old and unfit. The rate of complications and the end results appear to justify using transurethral resection as the method of choice for prostatectomy whenever it is feasible.

Entities:  

Mesh:

Year:  1978        PMID: 88983     DOI: 10.1111/j.1464-410x.1978.tb06208.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  17 in total

Review 1.  Review of current and future approaches to the management of benign prostatic hyperplasia.

Authors:  J C Gingell
Journal:  Postgrad Med J       Date:  1992-09       Impact factor: 2.401

2.  Reprocessing data to form QALYs.

Authors:  J Coast
Journal:  BMJ       Date:  1992-07-11

Review 3.  Purchasing for quality: still in the starting blocks?

Authors:  M Gill
Journal:  Qual Health Care       Date:  1993-09

Review 4.  Benign prostatic hyperplasia and its treatment.

Authors:  J B Stimson; S D Fihn
Journal:  J Gen Intern Med       Date:  1990 Mar-Apr       Impact factor: 5.128

5.  Transurethral resection of very large prostates. A retrospective study.

Authors:  P Waaddegaard; B J Hansen; S W Christensen; J T Andersen; R Iversen-Hansen; H G Iversen
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

6.  Measuring outcomes of hospital care using multiple risk-adjusted indexes.

Authors:  S DesHarnais; L F McMahon; R Wroblewski
Journal:  Health Serv Res       Date:  1991-10       Impact factor: 3.402

7.  The changing trend in prostatectomy in a district general hospital.

Authors:  G E Morris; J J Tate; R D Leach
Journal:  Ann R Coll Surg Engl       Date:  1985-11       Impact factor: 1.891

8.  Long term follow up of men with Alfuzosin who voided successfully following acute urinary retention*.

Authors:  V Palit; T Shah; C S Biyani; Y Elmasry; R Sarkar; G M Flannigan; R Puri
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

9.  Transurethral microwave treatment for benign prostatic hypertrophy: a randomised controlled clinical trial.

Authors:  A S Bdesha; C J Bunce; J P Kelleher; M E Snell; J Vukusic; R O Witherow
Journal:  BMJ       Date:  1993-05-15

10.  Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men.

Authors:  W M Garraway; E B Russell; R J Lee; G N Collins; G B McKelvie; M Hehir; A C Rogers; R J Simpson
Journal:  Br J Gen Pract       Date:  1993-08       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.